Building Diagnostics Without Building Hardware: Checktor’s Strategic Play
Автор: DiagnosingDx
Загружено: 2026-02-05
Просмотров: 31
Описание:
In this episode of Diagnosing Dx, I’m joined by Jake Lesinski, Co-founder and CEO of Checktor Biosciences, an ETH Zurich spin-out building a CRISPR-based chemistry platform designed to upgrade existing diagnostic systems rather than replace them.
We explore why speed, decentralisation, and practical integration, not hype — will define the next wave of molecular diagnostics. Jake shares how Checktor is approaching CRISPR from a clinical and commercial perspective, why matching PCR-level performance matters, and how distribution strategy can make or break even the strongest science.
This conversation is a grounded look at how diagnostics companies can scale responsibly, partner intelligently, and deliver real value to patients and healthcare systems.
Key takeaways:
🔹 Why rapid, accurate diagnostics remain one of healthcare’s biggest unmet needs
🔹 How CRISPR is finally finding its footing in real clinical workflows
🔹 Why upgrading existing diagnostic infrastructure beats starting from scratch
🔹 What founders need to understand about partnerships, validation, and scale
🔔 Subscribe to Diagnosing Dx for weekly conversations with leaders shaping the future of diagnostics.
#Diagnostics #CRISPR #MolecularDiagnostics #Biotech #LifeSciences #MedTech #DecentralisedTesting #PointOfCare #HealthcareInnovation #ClinicalDiagnostics #ETHZurich #StartupBiotech #SciencePodcast
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
